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Epidermal barrier acquisition during late murine gestation is accompanied by an increase in Akt kinase
activity and cJun dephosphorlyation. The latter is directed by the Ppp2r2a regulatory subunit of the Pp2a
phosphatase. This was accompanied by a change of Claudin-1 localisation to the cell surface and
interaction between Occludin and Claudin-1 which are thought to be required for tight junction
formation.
The aim of this study was to determine the nature of the barrier defect caused by the loss of AKT/
Ppp2r2a function. There was a paracellular barrier defect in rat epidermal keratinocytes expressing a
Ppp2r2a siRNA. In Ppp2r2a knockdown cells, Claudin-1 was located to the cytoplasm and its expression
was increased. Inhibiting cJun phosphorylation restored barrier function and plasma membrane
localisation of Claudin-1. Expression of the Rab3 GTPase activating protein, Rab3Gap1, was restored in
Ppp2r2a siRNA cells when cJun phosphorylation was inhibited. During normal mouse epidermal
development, Claudin-1 plasma membrane localisation and Rab3Gap1 cell surface expression were co-
incident with Akt activation in mouse epidermis, strongly suggesting a role of Rab3Gap1 in epidermal
barrier acquisition. Supporting this hypothesis, siRNA knockdown of Rab3Gap1 prevented plasma
membrane Claudin-1 expression and the formation of a barrier competent epithelium. Replacing
Rab3Gap1 in Ppp2r2a knockdown cells was sufﬁcient to rescue Claudin-1 transport to the cell surface.
Therefore these data suggest Rab3Gap1 mediated exocytosis of Claudin-1 is an important component of
epidermal barrier acquisition during epidermal development.
& 2013 Elsevier Inc. All rights reserved.Introduction
A principle cause of mortality and morbidity in severely pre-
mature births is the inability of epithelia such as the epidermis to be
barriers to the external environment. A better understanding of the
mechanisms of epidermal barrier acquisition could lead to novel
therapies (Smith et al., 2010; Kalia et al., 1998; Sharma et al., 2007);
however, this process is difﬁcult to investigate in the human foetus.
Murine epidermal barrier acquisition occurs in the same way as in
humans: a “wave” of barrier competence passes across the epider-
mis and converges at the dorsal and ventral midlines (Hardmanll rights reserved.
Institute of Child Health,
207 905 2882.
’Shaughnessy).et al., 1998). Within 24 h, the epidermis becomes impermeable to
small solutes and forms a barrier to dye penetration (Hardman
et al., 1998; Byrne et al., 2010). The serine–threonine kinase Akt is
activated coincident with barrier acquisition and Akt inhibition
prevents barrier acquisition (O'Shaughnessy et al., 2009). cJun
dephosphorylation occurs transiently, in an Akt-dependent manner,
during epidermal barrier acquisition (O'Shaughnessy et al., 2009).
When cJun dephosphorylation is prevented in skin explants, barrier
acquisition is abolished. Furthermore, siRNA knockdown of
Ppp2r2a, a regulatory subunit of the Pp2a phosphatase which
targets cJun for dephosphorylation, delays barrier acquisition in
organotypic cultures (O'Shaughnessy et al., 2009). Jun Kinase
inhibition restores barrier function in these cultures highlighting
the critical role of cJun dephosphorylation by Ppp2r2a in epidermal
barrier function. To date the downstream targets of cJun phosphor-
ylation during epidermal barrier acquisition are not known.
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be provided solely by the stratum corneum, more recent work has
demonstrated that tight junction complexes are critical compo-
nents of the epidermal barrier. Tight junctions in simple epithelia
such as the lung and gut provide a permeability barrier preventing
paracellular diffusion of solutes and ions (Tsukita and Furuse,
2002). Tight junctions are composed of the obligate component
Occludin (Furuse et al., 1993) and proteins known as Claudins
(Furuse and Tsukita, 2006). The importance of Claudin-1 is
demonstrated in knockout mice which die from epidermal dehy-
dration due to severely impaired barrier function (Furuse et al.,
2002). Although Occludin null mice have no gross skin barrier
defect (Saitou et al., 2000), Occludin knockdown cells, including
keratinocytes, exhibit reduced paracellular barrier function (Cong
et al., 2013; Kirschner et al., 2013). Claudin-1 is expressed prior to
epidermal barrier acquisition (Troy et al., 2007; Lopardo et al.,
2008), while Occludin is expressed in the uppermost granular
layer just prior to birth (Morita et al., 1998). Although both are
expressed during barrier acquisition, the relationship between
Claudin-1 and Occludin expression and localisation and barrier
acquisition in epidermis has not yet been addressed.
The transport of tight junction components to the cell surface
involves the coordinate regulation of Rab GTPases, with various Rabs
being implicated in the transport of apical junctions in epithelia. Only
2 of the 60 Rabs can be detected in the vicinity of tight junctions in
epithelia (Marzesco and Zahraoui, 2005; Weber et al., 1994). In
particular Rabs 3 and 13 are required for the dynamic endocytic
recycling of Occludin and Claudin-1 to the cell surface (Morimoto
et al., 2005; Yamamura et al., 2008; Yamamoto et al., 2003). Save for a
role for Rab3A in melanosome transport in melanocytes (Scott and
Zhao, 2001), nothing is known about the expression and function of
these Rabs in epidermal barrier acquisition.
In this study, we show that the cell surface localisation of Claudin-
1 and association with Occludin occur during epidermal develop-
ment and that this is concomitant with Akt activation and Ppp2r2a
expression. siRNA knockdown of Ppp2r2a causes paracellular barrier
defects associated with the cytoplasmic accumulation of Claudin-1.
Jun Kinase inhibition rescues paracellular barrier function by restor-
ing Claudin-1 plasma membrane expression. We provide evidence
that Rab3-mediated exocytosis of Claudin-1 is concomitant with this
barrier rescue, and that the GTPase protein Rab3Gap1 is necessary for
cell surface Claudin-1 and Occludin Expression.Materials and methods
Immunoﬂuoresence and microscopy
Immunoﬂuoresence was performed using standard techniques.
Brieﬂy, keratinocytes were ﬁxed for 10 min at 4 1C in 4% paraf-
ormaldehyde in phosphate buffered saline (PBS), then permeabi-
lised in 0.2% Triton X-100 (Sigma, Gillingham, UK) for 30 min.
Following this samples were incubated with the primary anti-
bodies. These were: rabbit anti pSer473 Akt 1/10; rabbit anti
pSer63 cJun 1/10 (both Cell Signalling Technologies, Danvers,
USA); rabbit anti Claudin-1 (Invitrogen, Paisley, UK) 1/25; mouse
anti Occludin (Invitrogen, Paisley, UK) 1/25; rabbit anti PR55alpha
(Santa Cruz Biotechnologies, Santa Cruz, US) 1/25; rabbit anti
Zonula Occludins-1 (Santa Cruz Biotechnologies, Santa Cruz, US) 1/
50; Mouse anti Rab3 (BD Biosciences, Oxford, UK) 1/25. Rabbit anti
Rab3Gap1 (Abgent, Cambridge, UK) 1/25. Antibody detection was
performed using either the Elite Avidin–Biotin-Complex system
and DAB (Vector Laboratories, Burlingame, US) or Alexa 488
(green) and 536 (red) conjugated secondary antibodies (Molecular
Probes, Invitrogen, Paisley, UK ) at 1/800. Cells and Organotypic
cultures were counterstained using haemotoxilin forimmunohistochemistry and 4′,6-diamidino-2-phenylindole (DAPI)
for immunoﬂuoresence. Images were taken with a Nikon Eclipse
E600 microscope with a Coolsnap digital camera (MediaCyber-
netics, Bethesda, MD,USA) and ImagePro 6.0 software (MediaCy-
bernetics), or a Zeiss laser scanning confocal microscope. Image
analysis was performed using ImageJ (http://rsb.info.nih.gov/ij/).
Proximity ligation analysis
Proximity ligation analysis (PLA assay, OLink Bioscience,
Uppsala, Sweden; (Soderberg et al., 2006)), determines in situ
whether 2 proteins are within 38 nm of each other, and potentially
interact. PLA was performed according to manufacturer's protocols
on frozen embryonic mouse sections and REKs ﬁxed in 4%
paraformaldehyde and 0.2% Triton-X 100. Occludin and Claudin-
1 or Zo-1 and Occludin primary antibodies were simultaneously
incubated at 1/25 concentrations. Subsequently sections or cells
were incubated for 2 h at 37 1C with a 1:5 dilution of the
secondary antibodies conjugated with complementary DNA, anti-
mouse+ and anti-rabbit−(598 nm excitation). DNA strands were
hybridised with a speciﬁc probe, DNA was synthesised by rolling
circle ampliﬁcation and visualised by ﬂuorescent oligonucleotides
that hybridise to the synthesised DNA, with a red dot by ﬂuores-
cence microscopy indicating a positive result. PLA was analysed by
using the spot ﬁnding algorithms in the ImageJ software suite.
siRNA constructs, rat epidermal keratinocyte culture and organotypic
culture
SureSilencing shRNA plasmids (Qiagen, Paisley, UK) to rat
Ppp2r2a (shRNA2-TGACTGGATCCTACAATAATT) (O'Shaughnessy
et al., 2009) and Rab3Gap1 (shRNA1-ATAGCCCATTCCAGCAAAGTT,
shRNA4-CGACAGTCTAACATACAAACT) were transfected into rat
epidermal keratinocytes (REKs) using lipofectamine plus (Invitro-
gen, Paisley, UK). A Myc tagged Rab3Gap1 expressing plasmid
(OriGene, Rockville, Maryland, USA) was transiently transfected
into Ppp2r2a knockdown cells using lipofectamine 2000 (Qiagen,
Paisley, UK). REKs were selected when necessary in 100 μM G418
(Invitrogen, Paisley, UK) and passaged in DMEM +10% foetal calf
serum. Organotypic culture was performed as described in
O'Shaughnessy et al., 2007: Brieﬂy, 2105 REKs were cultured
under selection on de-epidermised dermis (Euro Skin Bank,
Beverwijk, Netherlands). Conﬂuent cultures were raised to the
air–liquid interface and cultured for up to 10 days. Organotypic
cultures were ﬁxed in 4% paraformaldehyde prior to the haemo-
toxilin barrier assay, or embedded in OCT for cryosectioning. For
visualising barrier competence, organotypic cultures were passed
up and down a methanol gradient, placed in 1% haemotoxilin in
water for 1 min, and embedded in parafﬁn.
The Jun Kinase inhibitor SP600125 (Sigma, Gillingham, UK),
was added to submerged conﬂuent cultures for 24 h at a concen-
tration of 50 nM. Organotypic cultures were treated every 24 h
with 50 nM SP600125 or vehicle (DMSO) from 5 days post-raising
to the air–liquid interface. Concanamycin C (Sigma, Gillingham UK)
was added to submerged conﬂuent cultures at a concentration
2 μM for 2 h prior to further western and imunoﬂouresence
analysis, and for up to 24 h for Transepidermal electrical resistance
and FITC-dextran penetration experiments
Analysis of TEER and FITC dextran penetration
REKs were seeded at conﬂuent density on Thincert™ (Greiner)
cell culture inserts (mean pore size of 0.4 uM). TEER was measured
every 24 h using an Evometer (World Precision Instruments ltd,
Stevenage, UK) ﬁtted with chopstick electrodes. Monolayer resis-
tance was normalised to the surface area of the cell culture insert
Fig. 1. Expression of Ppp2r2a correlates with pAKT activation, cJun dephosphorylation and interaction between Claudin-1 and Occludin during epidermal
development. (A) Representative data from immunoﬂuorescent analysis of Ppp2r2a, pSerAkt, and pcJun, and Claudin-1 and Zo-1 of E15.5 and E16.5 embryonic epidermis
from 3 different embryos. (B) Representative data from a proximity ligation experiment between Occludin and Claudin-1 and Occludin and Zo-1 antibodies in triplicate
embryos. A red dot indicates that the two proteins are within 40 nm of each other, suggestive of interaction. Bar (A and B) 50 mm.
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value of the monolayer. A total of 6 individual experiments
containing 3 replicates within each experiment were performed.Measurement of FITC-dextran penetration was performed by
adding FITC-dextran at a ﬁnal concentration of 0.2 mg/ml to the
apical side of the monolayer. Basal medium was collected after 3 h
Fig. 2. Ppp2r2a knockdown cells have a defective paracellular barrier and altered cell surface expression of tight junction components. (A) Haemotoxilin and Eosin
stain of scrambled control and Ppp2r2a kd cultures 3,5,7 and 10 days post raising to the air–liquid interface. Lower 2 rows are the corresponding whole mount haematoxylin
staining, showing delay in outside-in barrier acquisition in the Ppp2r2a kd organotypic cultures. (B) 4 kDa FITC-dextran penetration in post-conﬂuent cells. Error bars are s.d.
for triplicate results, and data is representative of n¼6 experiments. (C) Confocal microscopy of Immunoﬂuoresence staining of pcJun, Total cJun, Claudin-1, Zo-1 and
Occludin in organotypic culture. (D) Immunoﬂuoresence of Claudin-1, Zo-1 and Occludin in scrambled control and Ppp2r2a kd cells in post-conﬂuent culture. (E) Western
blot of Ppp2r2a, Occludin and Claudin-1, and other Tight junction components differentially expressed in Ppp2r2a kd cells, conﬁrming Ppp2r2a knockdown and the
up-regulation of Claudin-1 and Jam-A. Bar 100 mm (A), 50 mm (C), and 10 mm(D).
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curve using a Wallac 1420 Victor2 ﬂuorimeter (Wallac OY, Fin-
land). The excitation and emission wavelengths were 485 nm and535 nm respectively. The data shown are mean7standard devia-
tion. Data was analysed using MannWhitney U test for non-
parametric data or students T test as appropriate.
Fig. 3. Jun Kinase inhibition restores cell surface expression of tight junction components in Ppp2r2a siRNA expressing cells. (A) 4 kDa FITC dextran penetration
experiment at 5 days post conﬂuence comparing scrambled controls, Ppp2r2a kd cells alone or treated with the JNK inhibitor SP600125. *, p-value 0.001, Two-tailed t-test.
Error bars are s.d. (B) pcJun and Claudin-1 immunoﬂuoresence in Scrambled controls, siRNA expressing alone or treated with SP600125, showing restoration of normal levels
of pcJun and normal localisation of Claudin-1. This correlated with a reduction in hyperkeratosis in the SP600125 treated organotypics. (C) Claudin-, Zo-1 and Occludin
immunoﬂuorescence in Ppp2r2a siRNA kd cells alone or treated with SP600125. (D) Western blot analysis of Occludin, Claudin and Zo-1 in the same cells. Gapdh is the
loading control. Numbers indicate the fold increase compared to scrambled controls. E. Proximity ligation analysis of Claudin-1 and Occludin and Zo-1 and Occludin
interaction in Ppp2r2a kd cells and Ppp2r2a kd cells treated with the Jun Kinase inhibitor SP600125, (*po0.05, **po0.001, n¼3). Bars 50 mm (B) and 10 mm (C, E).
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Protein lysates were prepared from REKs in total lysis buffer,
Tris HCl pH 7.5, 5% SDS and 20% beta-mercaptoethanol, Lysates
were separated on 7.5–10% SDS/polyacrylamide gels and trans-
ferred onto nitrocelluose ﬁlters (Hybond C+ – Amersham). Primary
antibodies and concentrations were as follows: rabbit anti PR55a
(Ppp2r2a) (Santa Cruz Biotechnologies, Santa Cruz, US) 1/500;
rabbit anti cJun (Cell Signalling Technologies, Danvers, USA) 1/100;
rabbit anti pSer63 cJun (Cell Signalling Technologies, Danvers,
USA) 1/100; rabbit anti Claudin-1 (Invitrogen, Paisley, UK) 1/500;
mouse anti Occludin (Invitrogen, Paisley, UK ) 1/500; Rabbit anti
Zonula Occludins-1 (Santa Cruz Biotechnologies, Santa Cruz, US) 1/
500; Mouse anti Rab3 (BD biosciences, Oxford, UK) 1/100. Rabbit
anti Rab3Gap1 (Abgent, Cambridge, UK) 1/100; Rabbit anti Exoc3
(Proteintech, Chicago, Illinois, USA) 1/500; Rabbit anti Psmd4 (Cell
Signalling Technologies, Danvers, USA) 1/500; Mouse anti c-Myc
(Clone 9E10) (Cambridge Bioscience, Cambridge, UK) 1/500;
mouse anti Gapdh (Millipore, Watford, UK) 1/1000 Primary anti-
body incubations were in PBS-Tween or TBST (100 mM Tris HCl,
0.2 M NaCl, 0.1% Tween-20 (v/v)) containing 5% bovine serum
albumin (Sigma, Gillingham, UK) overnight at 4 1C or for 1–2 h at
room temperature. Secondary antibody incubations were in 5%
skimmed milk powder for 1 h at room temperature. The following
concentrations were used; swine anti-rabbit HRP 1:5000; rabbit
anti-mouse HRP (DakoCytomation, Cambridge, UK) 1:2000; don-
key anti-goat HRP (Jackson Immunoresearch, Newmarket, UK)
1:3000. Protein was visualised using the ECL plus kit (GE Health-
care, Buckinghamshire, UK). Western blot exposures were scanned
and then densitometry analysis was performed where necessary
using the ImageJ suite (http://rsb.info.nih.gov/ij/).
Microarray analysis and analysis of gene expression data
Probes were synthesised from RNA extracted from triplicate
scrambled control cultures and duplicate Ppp2r2a kd cultures and
kd Cultures treated for 24 h with 50 nM SP600125. This was
hybridised to Affymetrix Rat Exon ST 1.0 Arrays (Affmetrix, Santa
Clara, CA, USA). This was performed by the UCL genomics core
facility. Microarray data were normalised using mas5 of affy.
Differentially expressed genes were identiﬁed in Ppp2r2a kd cells
and kd cells treated with SP600125 by po0.05 considering a false
discovery rate by the Bioconductor package limma. Hierarchical
clustering was performed according to Euclidean distance using
the complete agglomeration method. Over-represented Gene
Ontology (GO) groups were determined using DAVID (Database
for Annotation, Visualisation and Integrated Discovery—http://
david.abcc.ncifcrf.gov/). GO groups were over-represented if their
fold enrichment was 2-fold or higher and the p-value was less
than 0.05 (an EASE score of 1.3 or higher in DAVID). Interactions of
selected genes were identiﬁed using STRING (Search Tool for the
Retrieval of Interacting Genes/Proteins http://string-db.org).Results
1.1. Ppp2r2a is necessary for plasma membrane localisation of tight
junction components and formation of the paracellular barrier
To begin with, we sought to clarify the relationship between
Ppp2r2a expression and tight junction protein expression. In
agreement with previous work we showed that Ppp2r2a expres-
sion was concomitant with known markers of epidermal barrier
acquisition in the mouse such as phosphorylation of Akt and the
dephosphorylation of cJun (Fig. 1A, (O'Shaughnessy et al., 2009)).
Prior to barrier acquisition, both Claudin-1 and Zonula Occuldins-1(Zo-1) expression was cytoplasmic. However post barrier acquisi-
tion both proteins were found predominantly at the cell surface,
suggesting that cell surface expression is intimately associated
with barrier acquisition (Fig. 1A). Proximity ligation analysis
indicated a potential interaction between Claudin-1 and Occludin
and between Zo-1 and Occludin during this barrier acquisition
period (Fig. 1B). We therefore tested whether barrier defects
correlated with tight junction defects using Ppp2r2a shRNA
expressing (Ppp2r2a kd) rat epidermal keratinocytes (REK).
Haemotoxilin penetration assays indicated that control organoty-
pic cultures acquired barrier function 3 days after being raised to
the air–liquid interface (Fig. 2A; (Byrne et al., 2010; O'Shaughnessy
et al., 2009)). FITC-dextran permeability decreased markedly in
scrambled controls 2–4 days post conﬂuence, suggesting forma-
tion of a paracellular barrier. This was consistent with haemotox-
ilin penetration data in organotypic culture. 4 kDa FITC-dextran
permeability was greater in the siRNA expressing cultures
(Fig. 2B), suggesting that Ppp2r2a kd cells had a speciﬁc defect
in their paracellular barrier. Barrier function was restored in the
Ppp2r2a kd cultures concomitant with hyperkeratosis.
We then examined the expression of tight junction compo-
nents in organotypic cultures (Fig. 2C). Claudin-1 was localised to
the cell surface in the upper cell layers in the scrambled control
organotypic cultures. In contrast, Claudin-1 expression was
increased, in more cell layers in and was more cytoplasmic in
Ppp2r2a kd cultures. In addition the ﬂattened appearance of the
granular layer cells was lost in the siRNA expressing cultures. Cell
surface expression of Zo-1 was also lost in siRNA expressing
organotypic cultures. Occludin expression was continuous in the
granular layer of control organotypic cultures, while in Ppp2r2a kd
cultures, Occludin expression was patchy and discontinuous
(Fig. 2C). In post conﬂuent cell culture (Fig. 2D), cell surface
localisation of Claudin-1 and Zo-1 was reduced, and cytoplasmic
expression was increased. Occludin expression, although still at
the cell surface was discontinuous, consistent with protein expres-
sion in organotypic culture.
Gene array analysis revealed 4 up-regulated and 23 down-
regulated genes related to cell–cell junctions in the Ppp2r2a kd
cells compared to controls (Supplementary Fig. S1). Claudin-1 was
the most up-regulated cell–cell junction gene in the Ppp2r2a kd
cells (24 fold), and Jam-A was also up-regulated. Western blot
conﬁrmed the increased expression of Claudin-1 and Jam-A in the
Ppp2r2a kd cells compared to scrambled control cells (Fig. 2E).
Inhibiting cJun phosphorylation rescues tight junction protein
expression and localisation and partially restores barrier function in
Ppp2r2a siRNA expressing cells
Since previously, we showed that a JNK inhibitor SP600125,
restores barrier function measured by dye penetration in Ppp2r2a
kd cells in organotypic culture (O'Shaughnessy et al., 2009), we
investigated the mechanism of this rescue in the context of the
changes in the expression and localisation of Claudin-1, Zo-1 and
Occludin. Treatment with SP600125 for 24 h in post-conﬂuent
cells resulted in a decrease in FITC-dextran permeability (Fig. 3A),
suggesting that restoration of the paracellular barrier was at least
partly responsible for restoration of barrier function. This treat-
ment was also sufﬁcient to reduce hyperkeratosis in the Ppp2r2a
siRNA kd organotypic cultures (Fig. 3B).
Treatment of Ppp2r2a kd organotypic cultures with SP600125
restored Claudin-1 expression to the cell surface and to the upper
cell layers (Fig. 3B), and restored normal granular layer cell shape to
the organotypic cultures. This suggested that restoration of tight
junction protein expression to the cell surface correlated with
barrier restoration. In conﬂuent keratinocytes, SP600125 treatment
caused redistribution of Claudin-1 and Occludin back to the cell
Fig. 4. Genes involved in exocytosis and the regulation of ubiquitin-dependent proteolysis are altered in Ppp2r2a siRNA expressing cells and restored by Jun Kinase
inhibition. (A) Clusters of differentially expressed genes were identiﬁed in the Ppp2r2a kd cells, both non-rescued and rescued by SP600125 treatment. The number in the
corner is the number of differentially expressed genes in that cluster (% of all differentially expressed genes). (B) Graphical representation of over-represented gene ontology
groups in differentially expressed and SP600125 rescued genes, groups with an asterisk were investigated further. The blue line denotes the po0.05 signiﬁcance value.
(C) Table of the differentially expressed genes in each of the indicated gene ontology groups. Fold reduction in the Ppp2r2a kd cells is shown in brackets. (D and E) STRING
networks of interacting down-regulated and SP600125 rescued genes involved in the proteasome complex (D) and Exocytosis (E).
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Co-localisation of Claudin-1 and Occludin as the cell surface was
restored by SP600125 treatment (Supplementary Fig. S2). Claudin-1
protein levels per sewere reduced by SP600125 treatment (Fig. 3D),
with no change in Zo-1 and Occludin levels observed. We used
proximity ligation analysis in conﬂuent culture and determined that
the interaction between Claudin-1 and Occludin and between Zo-1
and Occludin we observed in Scrambled controls and lost in
Ppp2r2a siRNA expressing cells was restored with SP600125 treat-
ment (Fig. 4E). Therefore SP600125 treatment partially rescued
epidermal barrier function by restoring cell-surface expression and
interaction of tight junction components.
Ppp2r2a knock down results in altered expression of genes involved in
exocytosis which are rescued by SP600125 treatment
We hypothesised that Ppp2r2a kd cells exhibited defective cell
surface transport of Claudin-1 which was corrected by SP600125
treatment. To test this we examined gene expression in scrambled
control cells, Ppp2r2a kd cells and Ppp2r2s kd cells treated for 24 h
with SP600125 (Fig. 4A). There were 1724 genes down-regulatedand 1331 genes up-regulated by more than 1.5 fold in the Ppp2r2a
kd cells (Fig. 4A). We examined the over-represented gene
ontology groups in the differentially expressed genes (Supplemen-
tary Fig. S3). Genes involved in ubiquitination and protein local-
isation were among the down regulated genes, while genes
involved in negative regulation of apoptosis were among the
up-regulated genes.
493 down-regulated genes (28%) and 495 up-regulated genes
(37%) were rescued by SP600125 treatment. We also examined the
gene ontology groups that were over-represented in each of these
clusters. Although there were no signiﬁcantly over-represented
gene ontology groups in the up-regulated and rescued genes, in
the down-regulated, restored by SP600125 group, there were
genes in involved in ubiquitination and protein transport (Fig. 4B
and C). We identiﬁed networks of interacting genes speciﬁcally
involved in the proteasome complex and with Exocytosis (Fig. 4D
and E). We identiﬁed important proteins in these networks for
further analysis. Psmd4 (S5a) is a component of the proteasome
complex that binds polyubiquintinated proteins, targeting them
for degradation by the proteosome (Ferrell et al., 1996), Exoc3
(Sec6), a component of the 7-protein exocyst protein complex that
Fig. 5. Inhibition of exocytosis impairs paracellular barrier function, Claudin-1 expression and localisation. (A) Confocal microscopy of Rab3Gap1, Claudin-1 and Rab3
in post-conﬂuent REKs treated for 2 h with the exocytosis inhibitor Concanamycin C (Con C) or vehicle alone (DMSO). (B) Western blot analysis of Claudin-1, Rab3 and
Rab3Gap1, Exoc3, Psmd4 and ubiquitin in keratinocytes treated with Concanamycin C for 2 h. Gapdh is the loading control. (C) Changes in Transepidermal electrical
resistance (TEER) in response to Concanamycin C treatment for 24 h. (D) FITC dextran penetration in cells treated with Concanamycin C for 24 h. Error bars in C and D are s.d.
for triplicate experiments representative of n¼6. Bar 10 mm (A),
G. Youssef et al. / Developmental Biology 380 (2013) 274–285 281targets vesicles to the cell surface for exocytosis and transport of
plasma membrane proteins (Inoue et al., 2003), and Rab3Gap1 a
Rab3 GTPase activating protein which recycles Rab3 for further
rounds of exocytosis (Sakane et al., 2006).
To determine whether inhibition of exocytosis was required to
increase Claudin-1 expression and prevent cell surface localisation,
we treated cells with the toxin Concanamycin C, which inhibits
exocytosis by inhibiting vacuolar ATPase (Kataoka et al., 1994).
Concanamycin C treatment for 2 h prevented Rab3Gap1 plasma
membrane expression. Furthermore Claudin-1 was cytoplasmic
and co-localised with Rab3 in the nucleus (Fig. 5A). By western
blot, treated cells had increased levels of Claudin-1 and Occludin,
and Exoc3 while levels of Rab3Gap1 and Exoc3 were unchanged
(Fig. 5B). There was increased expression of Psmd4 and an increase
in ubiquitinated protein species overall, suggesting that a decrease
in proteasome-mediated degradation was unlikely to be involved
in the accumulation of cytoplasmic Claudin-1 (Fig. 5B).Paracellular barrier function as determined by Transepithelial
electrical resistance (TEER) and FITC-dextran penetration was
reduced by concanamycin C treatment over a 24 h period
(Fig. 5C and D). Therefore we show that inhibition of exocytosis
is necessary and sufﬁcient for the increased expression and
cytoplasmic localisation of Claudin-1, and the disruption of barrier
function.
By Western blot we conﬁrmed the reduction of Rab3Gap1 and
Exoc3 expression in Ppp2r2a kd cells and restored expression in
response to SP600125 treatment (Fig. 6A). Rab3Gap1 expression
was increased within 30 min of SP600125 treatment, whereas
Exoc3 expression increased only slightly after 8 h of SP600125
treatment. This correlated with loss of cJun phosphorylation
(Fig. 6B). The predominant Rab3Gap1 protein in rat epidermal
keratinocytes was the short (80kd) isoform that is transcribed
from an alternate start site. ENCODE ChIP data from the UCSC
genome browser showed this DNAse hypersensitive region was
Fig. 6. Jun Kinase inhibition restores Rab3Gap1 expression and Claudin-1 cell surface expression. Cell surface Rab3Gap1 correlates with barrier acquisition during
development. A. Western blot analysis of Rab3Gap1 and Rab3 and Exoc3 in response to SP600125 treatment in Ppp2r2a kd cells. Numbers denote fold change in intensity
compared to Scrambled controls after normalisation by levels of Gapdh, the loading control. (B) Western blot of Rab3Gap1, Rab3 and Exoc3 in REKs treated with SP600125
over an 8 h period. Note the reduction in phosphorylated cJun (pcJun) from 30 min correlates with the induction of Rab3Gap1 C. Immunoﬂuorescence of Rab3Gap1 and Co-
immunoﬂuorescence of Claudin-1 and Rab3 in conﬂuent scrambled, Ppp2r2a kd cells and Ppp2r2a kd cells treated with SP600125. D. Immunoﬂuorescence of pcJun, pSerAkt,
Ppp2r2a, Claudin-1 and Rab3Gap1 in E15.5 (Pre-barrier) and E17.5 (Post barrier) mouse epidermis, showing cell surface localisation of both Rab3Gap1 and Claudin-1 post
barrier acquisition. Dotted line indicates the dermal epidermal boundary. Bar 10 mm (C) and 50 mm (D).
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(cJun) binding sites that were conserved in Human, Rat and Mouse
in close proximity to the TATA box, suggesting that cJun binding
could interfere with basal transcription from this site (Supple-
mentary Fig. S4). Loss of Rab3Gap1 in Ppp2r2a kd conﬂuent rat
epidermal keratinocytes correlated with loss of cell surface
co-localisation of Rab3 and Claudin-1. Cell surface expression of
Rab3, Claudin-1 and Rab3Gap1 was restored with SP600125
treatment. (Fig. 6C), strongly suggesting that Rab3-mediatedexocytosis was required for Claudin-1 transport and tight
junction-related barrier function.
Epidermal barrier acquisition correlated with cell surface Claudin-1
and Rab3Gap1 expression
Barrier acquisition correlates with a transient Akt activation
and cJun dephosphorlyation during late mouse embryogenesis
(O'Shaughnessy et al., 2009). Using these as proxies for barrier
Fig. 7. Knockdown of Rab3Gap1 prevents cell surface localisation of Claudin-1 and Occludin. Rab3Gap1 rescues Claudin-1 localisation and expression in Ppp2r2a kd
cells. (A) Immunoﬂuoresence of Rab3Gap1 in Scrambled controls and in two shRNA knockdowns of Rab3Gap1 (siRNA1 and siRNA4). (B) Western blot of Rab3Gap1 kd cells of
Rab3Gap1, Claudin-1, Rab3a, Occludin, Zo-1, Exoc3 and Psmd4. Gapdh is the loading control. (C) Graph showing the mean percentage intensity in both kd lines (siRNA)
compared to Scrambled controls (Scr) after normalisation by Gapdh. Error bars SD, *, po0.05 **,po0.005 (2-sided Students T-Test). (D) co-immunoﬂuorescence of Claudin-1
and Rab3, showing peri-nuclear co-localisation in post-conﬂuent Rab3Gap1 kd cells. E. Immunoﬂuorescent analysis of Rab3Gap1 in conﬂuent scrambled and Rab3Gap1 kd
conﬂuent keratinocytes. F. Expression of Claudin-1 in conﬂuent scrambled controls, Ppp2r2a kd cells and kd cells transiently transfected with Rab3Gap1 (representative of
2 separate transfections). G. Western blot of Scrambled, Ppp2r2a kd cells and kd cells transfected with a Myc-tagged Rab3Gap1 (arrowhead). Numbers denote fold change in
intensity of Claudin-1, Exoc3 and Rab3Gap1 compared to Scrambled controls after normalisation by levels of Gapdh, the loading control Bar 10 mm (A, D, E, F), 50 mm (E (low
mag view)).
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Rab3Gap1 in vivo in E15.5 and E17.5 mouse embryos, as this is
the time period encompassing the barrier acquisition period
(Fig. 6D). Claudin-1 expression was cytoplasmic pre-barrier, while
expression was cell-surface in post barrier epidermis. Rab3Gap1
expression was increased and it too was on the cell surface.
Therefore Rab3Gap1 cell surface localisation correlated with
barrier acquisition in vivo.
Rab3Gap1 is necessary for cell surface expression of Claudin-1 and
Occludin and stratiﬁcation
To determine whether Rab3Gap1 was necessary for the localisa-
tion of Occludin and Claudin to the cell surface, we knocked down
Rab3Gap1 expression in REKs by shRNA expressing plasmids (Rab3-
Gap1 kd; Fig. 7A and B). In two separate Rab3Gap1 kd lines (siRNA1
and 4), we achieved signiﬁcant reduction of Rab3Gap1 expression
(10% and 50% of scrambled levels for si1 and 4, respectively). Rab3
was also reduced in both lines (Fig. 7B and C), There were no
signiﬁcant changes either in tight junction protein expression or the
expression of Exoc3 or Psmd4 (Fig. 7B and C). Claudin-1 accumulated
in the peri-nuclear region of differentiated keratinocytes and partially
co-localised with Rab3 (Fig. 7D). The cells did not form any kind of
transepidermal electrical resistance or act as a FITC-dextran penetra-
tion barrier and organotypic cultures were unable to stratify (not
shown). Consistent with this putative defect in paracellular barrier, in
post-conﬂuent cells Rab3Gap1 kd cells, Occludin expression was
discontinuous and reduced at the plasma membrane of knockdowncells (Fig. 7E). Claudin-1 did not co-localise with Occludin in the
knockdown cells (Fig. 7E). Transient transfection of Rab3Gap1 into
Ppp2r2a kd cells restored cell surface localisation of Claudin-1
(Fig. 7F) and reduced Claudin-1 expression levels (Fig. 7G). Exoc3
expression was also restored to levels in scrambled cells (Fig. 7G).
Therefore Rab3Gap1 is required for Claudin-1 cell surface expression
and epidermal barrier function, and the loss of Rab3Gap1 is
responsible for Claudin-1 trafﬁcking defects in the Ppp2r2a kd cells.Discussion
Taken together, these data suggest that the barrier defect in
Ppp2r2a siRNA expressing cultures is a defect in the formation of
tight junctions, speciﬁcally in Rab3-mediated Claudin-1 trafﬁcking
to the plasma membrane. Jun Kinase inhibition speciﬁcally res-
cued paracellular barrier function and Claudin-1 plasma mem-
brane localisation. Inhibition of exocytosis caused cytoplasmic
accumulation of Claudin-1 and reduced paracellular barrier func-
tion. These data suggest that constant exocytosis of Claudin-1 is
required for barrier function, and that constant turnover of surface
Claudin-1 occurs, consistent with the concept that epidermal tight
junctions are not static permeability clamps. Rather, constant cell
turnover in the epidermis requires tight junction turnover and
reformation whilst maintaining barrier function. Recent FRAP data
on Claudin turnover suggests that this is the case even in simple
epithelia (Sasaki et al., 2003; Yamazaki et al., 2011). Claudin-1
mutations have been observed in the rare disease NISCH
G. Youssef et al. / Developmental Biology 380 (2013) 274–285284syndrome (ichthyosis and neonatal sclerosing cholangitis); (Hadj-
Rabia et al., 2004; Feldmeyer et al., 2006). However, the complete
loss of expression of Claudin-1 observed in these cases only results
in a mild barrier defect. Epidermal Claudin-6 overexpression leads
to a permeability barrier acquisition delay (Enikanolaiye et al.,
2010;Turksen and Troy, 2002). Taken together this suggests that
the over-expression and mis-localisation of tight junction proteins
is more detrimental to epidermal barrier function than the loss of
these proteins.
There are reports of links between Jun Kinase and epithelial
barrier function. Campylobacter jejuni is a gut bacterium that
causes diarrhoea by disrupting tight junctions, which is associated
with Jun Kinase activation and redistribution of Occludin from the
cell surface to an intracellular region (Chen et al., 2006). JNK
inhibition in mammary epithelial cells increases Transepithelial
electrical resistance in a dose-dependent manner (Carrozzino
et al., 2009). This is consistent with our data showing a change
in Occludin and Claudin-1 distribution, increase in FITC-dextran
penetration in Ppp2r2a kd cells treated with the Jun Kinase
inhibitor SP600125, and rescued of the expression of genes
involved in exocytosis, including Rab3Gap1 and Exoc3.
Rab3 regulates exocytosis in a range of tissues (Weber et al., 1994).
However, Rab3 does not contribute to the establishment of Claudin-1
containing tight junctions in ﬁbroblasts (Yamamoto et al., 2003).
Keratinocytes, unlike simple epithelia or ﬁbroblasts, are stratiﬁed,
and although the organ as a whole can be regarded as somewhat
polarised, on a single cell level there is no clear evidence of
polarisation in the upper epidermis (Helfrich et al., 2007; Kirschner
et al., 2011). Rab3 may have a more widespread domain of exocytosis
in keratinocytes and, as suggested by our in vitro data, is important
for plasma membrane transport of Claudin-1 in keratinocytes. The
exocyst, a protein complex required for targeted exocytosis, and Rab3
functionally interact in the fast, calcium dependent, exocytosis of
neurotransmitters (Sudhof, 2004). As epidermal terminal differentia-
tion and the initial formation of cell–cell contacts in keratinocytes is
also calcium dependent, it is possible that the calcium gradient in the
epidermis elicits the rapid exocytosis of tight junction components.
In support of this is that siRNA knockdown of the calcium transporter
ATP2C1 gene, mutated in the inherited skin blistering disease Hailey-
Hailey disease, causes an increase in the expression of Claudins 1 and
4, and loss of cell-surface expression of tight junction proteins (Raiko
et al., 2012).
Recently a role for microtubules in epidermal barrier function
has been elucidated (Sumigray et al., 2012). Myosin IIA/B are
required for bundling of the actin cytoskeleton and the non-
centrosomal microtubule network in keratinocytes. Myosin IIA/B
knockout mice cannot transport Occludin properly to tight junc-
tions, leading to impairment of epidermal barrier function. Vesi-
cular Rabs such as Rab3 associate with microtubule motors for
transport (Horgan and McCaffrey, 2011). Therefore our data that
Rab3Gap1 is required for correct Rab3 mediated Claudin-1 traf-
ﬁcking and Occludin localisation is consistent with a requirement
for a microtubule network for barrier function.
Rab3Gap1 mutations cause Warberg microsyndrome, a disease
characterised by microcephaly, microphthalmia, microcornia, cat-
aracts, optic atrophy, cortical dysplasia, mental retardation, spastic
diplegia, and hypogonadism (Morris-Rosendahl et al., 2010;
Aligianis et al., 2005). No skin defects are reported suggesting that
the effect of these mutations in the epidermis may be less severe
that those we would predict from Rab3Gap1 loss, namely wide-
spread epithelial barrier disruption. We propose that Rab3Gap1
controls exocytosis of a Claudin-1 pool, causing rapid acquisition
of barrier function during development. Further investigation into
drugs, like SP600125, that can restore the exocytosis of tight
junction components, as well as the mechanisms of rapid barrier
acquisition during development, could lead to therapies to restorebarrier function not only in epidermis, but also other epithelia in
premature infants.Acknowledgements
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